4//SEC Filing
Drygin Denis 4
Accession 0001209191-22-005063
CIK 0001505512other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:14 PM ET
Size
5.4 KB
Accession
0001209191-22-005063
Insider Transaction Report
Form 4
Drygin Denis
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-12+400,000→ 400,000 totalExercise: $0.26Exp: 2032-01-11→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001819692
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:14 PM ET
- Size
- 5.4 KB